EVK has been the topic of a number of other reports. UBS Group set a €27.00 ($33.33) price objective on Evonik Industries and gave the company a sell rating in a report on Monday, January 8th. Barclays set a €35.50 ($43.83) target price on Evonik Industries and gave the stock a buy rating in a report on Monday, November 6th. DZ Bank reissued a buy rating on shares of Evonik Industries in a report on Wednesday, February 14th. Baader Bank set a €38.00 ($46.91) target price on Evonik Industries and gave the stock a buy rating in a report on Thursday, December 14th. Finally, Nord/LB set a €31.00 ($38.27) target price on Evonik Industries and gave the stock a neutral rating in a report on Friday, December 8th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and twelve have issued a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of €33.79 ($41.72).
Evonik Industries (FRA EVK) opened at €28.84 ($35.60) on Tuesday. Evonik Industries has a 1-year low of €26.78 ($33.06) and a 1-year high of €32.97 ($40.70). The company has a market capitalization of $13,430.00 and a price-to-earnings ratio of 18.73.
WARNING: “JPMorgan Chase & Co. Analysts Give Evonik Industries (EVK) a €25.00 Price Target” was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of United States and international copyright and trademark legislation. The legal version of this report can be viewed at https://www.tickerreport.com/banking-finance/3252493/jpmorgan-chase-co-analysts-give-evonik-industries-evk-a-25-00-price-target-2.html.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical quaternary derivatives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare sectors.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.